NEEDLE CONCEPT
Innovative injection technologies
for professionals in aesthetic medicine
a unique experience & expertise
French company founded in 2008,
Needle Concept® specializes in innovative medical techniques in the field of needles, particularly in the injection of dermal fillers.
Needle Concept® is
the creator of the
Magic Needle®, an exceptional flexible cannula, and the
U225®, the reference intradermal injector, hand-assembled by our experts in our workshops.
U225, the worldwide renowned intradermal injector
U225® - THE original
The reference intradermal injector
Thanks to its technical skills and
French know-how, Needle Concept® has designed a reliable, ergonomic, and easy-to-use intradermal injector for both right-handed and left-handed users. The
U225® can be used for treatments on the face, scalp, and other parts of the body, consistently and repetitively, with a wide range of injection frequencies.
U225® EVO
The injector for gynecological indications.
Developed in consultation with gynecologists, the
U225® EVO intradermal injector is specifically designed for external and internal treatments to correct the aesthetics and functional disorders of the female genital area.
Micro-cannulas and intradermal needles
magic needle
The flexible micro-cannula of excellence from Needle Concept that revolutionizes injection techniques.
In partnership with Dr. Bernard Hertzog, who, after various research efforts, designed the
Magic Needle® micro-cannula, Needle Concept® brings an innovative technique to the entire field of medicine (aesthetic, plastic, dermatological, dental, etc.) for less traumatic and more reliable injections for patients.
mesbio needle
Needle Concept's intradermal and hypodermic needles for micro-injections.
Our Mesbio® Needle are available in a wide range of gauges and lengths for your mesotherapy injections, botulinum toxin, and other applications. They fit onto Luer-lock bases with color codes compliant with ISO standards.
CDMO
Accompanying our partners at every stage of the product lifecycle is our CDMO mission.









